Policy Address

Promote Development of Chinese Medicine

191. To develop Hong Kong into a bridgehead for the internationalisation of Chinese medicine (CM), the Government will make use of Hong Kong's advantages in its healthcare system, regulatory regime, standard-setting, clinical research and trade, and other areas. We will publish the CM Development Blueprint next year, and take forward the following measures:

1. exploring the application of big data to foster international research collaboration on herb-drug interaction to discover more evidence of clinical significance, promoting the internationalisation of CM;

2. expanding integrated Chinese-Western medicine services to cover more diseases in which CM has an advantage, including respiratory diseases and knee osteoarthritis, and to progressively extend the cancer care programme to all hospital clusters;

3. rolling out the first Chinese Medicine Hospital and the permanent premises of the Government Chinese Medicines Testing Institute, which are expected to be completed and begin phased operation next year; and

4. organising the first edition of the Hong Kong Chinese Medicine Cultural Festival to promote the culture of CM in collaboration with the industry.